INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reckitt Benckiser Group plc - RBGLY

05.02.25 02:04 Uhr

Werte in diesem Artikel
Aktien

63,10 EUR -0,26 EUR -0,41%

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Reckitt Benckiser Group plc ("Reckitt" or the "Company") (OTCMKTS:RBGLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Reckitt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On March 15, 2024, an Illinois jury returned a $60 million verdict against Reckitt in a lawsuit finding that Reckitt's Mead Johnson Nutrition unit failed to adequately disclose the risks of necrotizing enterocolitis in its cow-milk-based Enfamil baby formula.  Following the verdict, Reckitt's American depositary receipt ("ADR") price fell $1.87 per ADR, or 14.05%, to close at $11.44 per ADR on March 15, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-reckitt-benckiser-group-plc---rbgly-302368183.html

SOURCE Pomerantz LLP

Ausgewählte Hebelprodukte auf Reckitt Benckiser

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Reckitt Benckiser

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Reckitt Benckiser Plc

Wer­bung

Analysen zu Reckitt Benckiser Plc

DatumRatingAnalyst
05.02.2025Reckitt Benckiser Market-PerformBernstein Research
04.02.2025Reckitt Benckiser Equal WeightBarclays Capital
03.02.2025Reckitt Benckiser NeutralJP Morgan Chase & Co.
03.02.2025Reckitt Benckiser BuyUBS AG
24.01.2025Reckitt Benckiser OutperformRBC Capital Markets
DatumRatingAnalyst
03.02.2025Reckitt Benckiser BuyUBS AG
24.01.2025Reckitt Benckiser OutperformRBC Capital Markets
09.12.2024Reckitt Benckiser OutperformRBC Capital Markets
01.11.2024Reckitt Benckiser OutperformRBC Capital Markets
18.09.2024Reckitt Benckiser BuyUBS AG
DatumRatingAnalyst
05.02.2025Reckitt Benckiser Market-PerformBernstein Research
04.02.2025Reckitt Benckiser Equal WeightBarclays Capital
03.02.2025Reckitt Benckiser NeutralJP Morgan Chase & Co.
23.01.2025Reckitt Benckiser NeutralJP Morgan Chase & Co.
08.01.2025Reckitt Benckiser Market-PerformBernstein Research
DatumRatingAnalyst
27.03.2024Reckitt Benckiser UnderperformJefferies & Company Inc.
19.03.2024Reckitt Benckiser UnderperformJefferies & Company Inc.
18.03.2024Reckitt Benckiser UnderperformJefferies & Company Inc.
28.02.2024Reckitt Benckiser UnderperformJefferies & Company Inc.
22.02.2024Reckitt Benckiser UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Reckitt Benckiser Plc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"